Robert G. Finizio, CEO at TherapeuticsMD, Inc. (TXMD), bought 70,000 shares at $2.74 ($192K) on 2019-08-20, disclosed to the SEC on 2019-08-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.74 | 35,000 | $96K | 50.0% |
| 2 | $2.74 | 35,000 | $96K | 50.0% |
| Total | $2.74 avg | 70,000 | $192K | 100% |
| Filing → |
| TXMD | BUY | 2020-06-08 | $35K | — | Filing → |
| TXMD | BUY | 2019-10-29 | $198K | — | Filing → |
| TXMD | BUY | 2019-08-12 | $310K | — | Filing → |